CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LLY — ELI LILLY & Co
CIK 884546
SAN FRANCISCO, CA
Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,424,297,586
-$763,931,813 QoQ
Shares Held
5,897,450
+2.4% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99552348896556.ToString("F0")%
Shared 0.ToString("F0")%
None 0.004476511034430136.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. LLY ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,181,780 | $1,140,294,678 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,424,297,586 | 5,897,450 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,188,229,399 | 5,758,206 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,297,514,333 | 5,632,391 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,178,010,303 | 5,359,653 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,334,002,368 | 5,247,548 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,887,084,848 | 5,035,084 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,283,714,806 | 4,835,220 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,368,472,986 | 4,825,016 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,636,387,309 | 4,674,260 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,658,437,554 | 4,560,553 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,382,338,597 | 4,435,311 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,038,794,409 | 4,347,295 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,481,508,385 | 4,313,984 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,566,577,000 | 4,282,137 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,360,463,113 | 4,207,401 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,244,031,602 | 3,836,880 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,108,043,995 | 3,869,274 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,045,762,014 | 3,785,975 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $859,066,773 | 3,718,099 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $841,339,299 | 3,665,647 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $669,944,179 | 3,586,041 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $605,980,604 | 3,589,082 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $529,805,025 | 3,579,280 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $638,503,900 | 3,889,048 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $527,047,635 | 3,799,363 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||